Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2000 Oct;55(Suppl 2):S54–S56. doi: 10.1136/thorax.55.suppl_2.S54

The importance of COX-2 inhibition for aspirin induced asthma

A Bennett
PMCID: PMC1765952  PMID: 10992560

Full Text

The Full Text of this article is available as a PDF (79.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andri L., Senna G., Betteli C., Givanni S., Scaricabarozzi I., Mezzelani P., Andri G. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy. 1994 Jan;72(1):29–32. [PubMed] [Google Scholar]
  2. Astarita C., Franzese A., Sproviero S., Scala G., Ferrara A. M., Raucci G., Altucci P. Epidemiologia delle reazioni avverse ai farmaci antiinfiammatori non steroidei. La nimesulide è tollerata dai pazienti con reazioni avverse ai FANS e modula nell'uomo la risposta cutanea all'istamina ed alla codeina. Recenti Prog Med. 1992 Oct;83(10):567–571. [PubMed] [Google Scholar]
  3. Bennett A. Overview of nimesulide. Rheumatology (Oxford) 1999 May;38 (Suppl 1):1–3. doi: 10.1093/rheumatology/38.suppl_1.1. [DOI] [PubMed] [Google Scholar]
  4. Bennett A., Villa G. Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Expert Opin Pharmacother. 2000 Jan;1(2):277–286. doi: 10.1517/14656566.1.2.277. [DOI] [PubMed] [Google Scholar]
  5. Berti F., Rossoni G., Buschi A., Robuschi M., Villa L. M. Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig. Arzneimittelforschung. 1990 Sep;40(9):1011–1016. [PubMed] [Google Scholar]
  6. Bianco S., Robuschi M., Petrigni G., Scuri M., Pieroni M. G., Refini R. M., Vaghi A., Sestini P. S. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs. 1993;46 (Suppl 1):115–120. doi: 10.2165/00003495-199300461-00024. [DOI] [PubMed] [Google Scholar]
  7. Famaey J. P. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Inflamm Res. 1997 Nov;46(11):437–446. doi: 10.1007/s000110050221. [DOI] [PubMed] [Google Scholar]
  8. Ferreira S. H. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 1993;46 (Suppl 1):1–9. doi: 10.2165/00003495-199300461-00003. [DOI] [PubMed] [Google Scholar]
  9. Ispano M., Fontana A., Scibilia J., Ortolani C. Oral challenge with alternative nonsteroidal antiinflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs. 1993;46 (Suppl 1):253–256. doi: 10.2165/00003495-199300461-00065. [DOI] [PubMed] [Google Scholar]
  10. Kosnik M., Music E., Matjaz F., Suskovic S. Relative safety of meloxicam in NSAID-intolerant patients. Allergy. 1998 Dec;53(12):1231–1233. doi: 10.1111/j.1398-9995.1998.tb03854.x. [DOI] [PubMed] [Google Scholar]
  11. Magni E. The effect of nimesulide on prostanoid formation. Drugs. 1993;46 (Suppl 1):10–14. doi: 10.2165/00003495-199300461-00004. [DOI] [PubMed] [Google Scholar]
  12. Ottonello L., Dapino P., Pastorino G., Dallegri F. Inhibition of the neutrophil oxidative response induced by the oral administration of nimesulide in normal volunteers. J Clin Lab Immunol. 1992;37(2):91–96. [PubMed] [Google Scholar]
  13. Pelletier J. P., Martel-Pelletier J. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage. Drugs. 1993;46 (Suppl 1):34–39. doi: 10.2165/00003495-199300461-00008. [DOI] [PubMed] [Google Scholar]
  14. Rossoni G., Berti F., Buschi A., Villa L. M., Bella D. D. New data concerning the antianaphylactic and antihistaminic activity of nimesulide. Drugs. 1993;46 (Suppl 1):22–28. doi: 10.2165/00003495-199300461-00006. [DOI] [PubMed] [Google Scholar]
  15. Senna G. E., Passalacqua G., Andri G., Dama A. R., Albano M., Fregonese L., Andri L. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs. Drug Saf. 1996 Feb;14(2):94–103. doi: 10.2165/00002018-199614020-00004. [DOI] [PubMed] [Google Scholar]
  16. Shah A. A., Murray F. E., Fitzgerald D. J. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity. Rheumatology (Oxford) 1999 May;38 (Suppl 1):19–23. doi: 10.1093/rheumatology/38.suppl_1.19. [DOI] [PubMed] [Google Scholar]
  17. Szczeklik A., Sladek K., Dworski R., Nizankowska E., Soja J., Sheller J., Oates J. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1608–1614. doi: 10.1164/ajrccm.154.6.8970343. [DOI] [PubMed] [Google Scholar]
  18. Szczeklik A., Stevenson D. D. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999 Jul;104(1):5–13. doi: 10.1016/s0091-6749(99)70106-5. [DOI] [PubMed] [Google Scholar]
  19. Tavares I. A., Bishai P. M., Bennett A. Activity of nimesulide on constitutive and inducible cyclooxygenases. Arzneimittelforschung. 1995 Oct;45(10):1093–1095. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES